Testing a new norovirus treatment in healthy adults
Part of Infections clinical trials.
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 49 years old
- You have a known secretor status (a genetic trait that affects norovirus susceptibility)
- You have not had norovirus or participated in norovirus research before
- You don't have chronic stomach or bowel problems
- You are not taking medicines that weaken the immune system
- You have a body weight above 45 kg and a BMI between 18 and 32
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a higher dose of an experimental vaccine (VIR-1388) that may help prevent infection with cytomegalovirus (CMV), a common virus that can be harmful to people with weakened immune systems and to unborn babies. The vaccine is given to healthy adults who already have CMV to see if it is safe and produces a good immune response.
This trial tests an investigational vaccine called INT101 to see if it can prevent norovirus, a common cause of stomach flu (vomiting and diarrhea). It is given to healthy adults to check its safety and how well it works before moving to larger studies.
This trial tests a new drug, EDI048, to see how well it works and how safe it is for treating cryptosporidium infection. It is for healthy volunteers who will be intentionally exposed to the infection under controlled conditions.
This study tests an antiviral medicine called FS-1 (brand name Efesovir) in adults hospitalized with COVID-19 who have risk factors for severe illness. The goal is to see if the drug can help them recover faster or avoid more serious complications.
This trial tests a new medicine in healthy people to see how safe it is and how the body handles it. It may help pave the way for future treatments.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
Hear when a new Norovirus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.